Founded in 1990 and headquartered in Taipei, Taiwan, CX Venture Group focuses on investing in technology and biotechnology companies. They typically invest in startups that are 2-3 years old and have a funding round with 5 participants. Their investments range from $10 to $50 million and they have a successful track record in fields such as therapeutics and biotechnology. One of their notable investments was in Cellerant Therapeutics in 2005, alongside other investors such as Novel Bioventures and MPM Capital.